Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (482) Arrow Down
Filter Results: (482) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (482)
    • People  (1)
    • News  (27)
    • Research  (403)
    • Events  (2)
  • Faculty Publications  (365)

Show Results For

  • All HBS Web  (482)
    • People  (1)
    • News  (27)
    • Research  (403)
    • Events  (2)
  • Faculty Publications  (365)
← Page 7 of 482 Results →

    Willy C. Shih

    Willy Shih is the Robert and Jane Cizik Professor of Management Practice in Business Administration.  He is part of the Technology and Operations Management Unit, and he teaches in the MBA and Executive Education Programs.  His expertise is in manufacturing, product... View Details

    Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
    • February 2010
    • Case

    Amyris Biotechnologies: Commercializing Biofuel

    By: Gary P. Pisano and Alison Berkley Wagonfeld
    In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the... View Details
    Keywords: Renewable Energy; Chemicals; Risk Management; Product Marketing; Product Development; Production; Environmental Sustainability; Commercialization; Biotechnology Industry; Brazil
    Citation
    Educators
    Purchase
    Related
    Pisano, Gary P., and Alison Berkley Wagonfeld. "Amyris Biotechnologies: Commercializing Biofuel." Harvard Business School Case 610-031, February 2010.
    • June 2006 (Revised April 2007)
    • Case

    BioScale

    By: H. Kent Bowen and Bradley R. Staats
    In 2004, Mark Lundstrom must decide on a funding method and strategic approach for BioScale, a biotechnology company that he founded. BioScale has developed a microchip-based bioanalytical platform that can be used to detect very small concentrations of cells, viruses,... View Details
    Keywords: Entrepreneurship; Science-Based Business; Capital; Financing and Loans; Partners and Partnerships; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Bowen, H. Kent, and Bradley R. Staats. "BioScale." Harvard Business School Case 606-100, June 2006. (Revised April 2007.)
    • July 2016
    • Case

    Product Portfolio Management at Genentech

    By: Kevin Schulman and Jamie Gresh
    Genentech, long the darling of the biotechnology industry, was acquired by Swiss pharmaceutical company Roche in 2009. The combined company retains the name Genentech in the US, but must now move to achieve the promises made at the time of this merger—to build from... View Details
    Keywords: Portfolio Management; Drug Development; Postmerger Integration; Marketing Strategy; Mergers and Acquisitions; Integration; Biotechnology Industry; Biotechnology Industry; United States
    Citation
    Educators
    Purchase
    Related
    Schulman, Kevin, and Jamie Gresh. "Product Portfolio Management at Genentech." Harvard Business School Case 317-012, July 2016.
    • February 2000 (Revised October 2000)
    • Case

    Kendle International Inc.

    By: Dwight B. Crane, Paul W. Marshall and Indra Reinbergs
    Candace Kendle and Christopher Bergen, the CEO and COO of Kendle International, Inc., are reviewing ways to finance the growth of their privately-owned company. Kendle is a contract research organization that conducts clinical drug trials for pharmaceutical and... View Details
    Keywords: Acquisition; Financing and Loans; Venture Capital; Stock Options; Banks and Banking; Debt Securities; International Finance; Financial Strategy; Management Skills; Private Ownership; Initial Public Offering; Biotechnology Industry; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Crane, Dwight B., Paul W. Marshall, and Indra Reinbergs. "Kendle International Inc." Harvard Business School Case 200-033, February 2000. (Revised October 2000.)
    • May 2007 (Revised September 2008)
    • Case

    Biocon Limited

    By: Krishna G. Palepu and Ananth Chepuri
    Biocon Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an innovation-led strategy. This new... View Details
    Keywords: Globalized Firms and Management; Innovation and Management; Leading Change; Growth and Development Strategy; Risk Management; Organizational Change and Adaptation; Biotechnology Industry; India
    Citation
    Educators
    Purchase
    Related
    Palepu, Krishna G., and Ananth Chepuri. "Biocon Limited." Harvard Business School Case 107-083, May 2007. (Revised September 2008.)
    • April 1993 (Revised October 1995)
    • Case

    ALZA and Bio-Electro Systems (A): Technological and Financial Innovation

    By: Josh Lerner and Peter Tufano
    To develop the next generation of risky products, ALZA, a mature and profitable biotechnology firm specializing in drug delivery systems, must raise $40 million. Organizational constraints and competitive concerns demand that the work be done inside the firm. However,... View Details
    Keywords: Risk and Uncertainty; Technological Innovation; Business Subsidiaries; Decision Choices and Conditions; Corporate Finance; Biotechnology Industry; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (A): Technological and Financial Innovation." Harvard Business School Case 293-124, April 1993. (Revised October 1995.)
    • December 1999 (Revised August 2001)
    • Case

    Millennium Pharmaceuticals, Inc. (A)

    By: Stefan H. Thomke and Ashok Nimgade
    Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
    Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Biotechnology Industry; Cambridge
    Citation
    Educators
    Purchase
    Related
    Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
    • January 2020
    • Case

    Celata Bioinnovations

    By: John R. Wells and Benjamin Weinstock
    In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
    Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
    • May 2009 (Revised August 2013)
    • Case

    The DiagnoFirst Opportunity

    By: Robert C. Pozen and Rukmini Balu
    John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a genetic test that identified a subset of prostate cancer patients with a high risk of clinical... View Details
    Keywords: Genetic Engineering; Genetically Modified; Genomics; Venture Capital; Patents; Genetics; Decision Choices and Conditions; Laws and Statutes; Investment; Science-Based Business; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Pozen, Robert C., and Rukmini Balu. "The DiagnoFirst Opportunity." Harvard Business School Case 309-112, May 2009. (Revised August 2013.)
    • 2010
    • Working Paper

    Venture Capital Investment in the Clean Energy Sector

    By: Shikhar Ghosh and Ramana Nanda
    We examine the extent to which venture capital is adequately positioned for the rapid commercialization of clean energy technologies in the United States. While there are several startups in clean energy that are well-suited to the traditional venture capital... View Details
    Keywords: Business Startups; Energy Generation; Venture Capital; Investment; Governing Rules, Regulations, and Reforms; Technological Innovation; Competition; Energy Industry; Energy Industry; United States
    Citation
    Read Now
    Related
    Ghosh, Shikhar, and Ramana Nanda. "Venture Capital Investment in the Clean Energy Sector." Harvard Business School Working Paper, No. 11-020, August 2010.

      Paul A. Gompers

      Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
      Keywords: information technology industry; information technology industry; information technology industry; information technology industry; information technology industry; information technology industry; information technology industry; information technology industry
      • September 2023 (Revised December 2023)
      • Case

      TetraScience: Noise and Signal

      By: Thomas R. Eisenmann and Tom Quinn
      In 2019, TetraScience CEO “Spin” Wang needed advice. Five years earlier, he had cofounded a startup that saw early success with a hardware product designed to help laboratory scientists in the biotechnology and pharmaceutical spaces more easily collect data from... View Details
      Keywords: Entrepreneurship; Business Growth and Maturation; Business Organization; Restructuring; Forecasting and Prediction; Digital Platforms; Analytics and Data Science; AI and Machine Learning; Organizational Structure; Network Effects; Competitive Strategy; Biotechnology Industry; Biotechnology Industry; United States; Boston
      Citation
      Educators
      Purchase
      Related
      Eisenmann, Thomas R., and Tom Quinn. "TetraScience: Noise and Signal." Harvard Business School Case 824-024, September 2023. (Revised December 2023.)

        Michael E. Porter

        Michael Porter is an economist, researcher, author, advisor, speaker and teacher. Throughout his career at Harvard Business School, he has brought economic theory and strategy concepts to bear on many of the most challenging problems facing corporations, economies... View Details

        Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
        • 02 Dec 2002
        • Research & Ideas

        The Secret of How Microsoft Stays on Top

        industry or the biotechnology industry? Both industries share similarities with software, in that firms codify their intellectual property into libraries that can be reused and... View Details
        Keywords: by Sean Silverthorne
        • Research Summary

        Overview

        The research activity of Stefano Denicolai regards the management of innovation and technology. His recent works investigate if and how the investment in intangible assets (IA) - especially knowledge assets, such as patents or copyright - impacts on the firm... View Details
        Keywords: Innovation Management; International Entrepreneurship; Intangible Assets; Open Innovation; Innovation and Management; Entrepreneurship; Competitive Strategy; Technology Industry; Technology Industry; Technology Industry; Technology Industry
        • September 2013 (Revised August 2014)
        • Case

        Claritas Genomics

        By: Robert F. Higgins and Matthew Preble
        Claritas Genomics was formed in January 2013 when BCH spun out its Genetics Diagnostic Lab into a fully commercial entity. Claritas offered over 100 genomic tests to detect a range of conditions, including autism and intellectual disabilities, and was developing new... View Details
        Keywords: Boston Children's Hospital; Genetic Engineering; Genetically Modified; Genetics Diagnostics; Health Care Industry; Healthcare IT; Healthcare Technology; Healthcare Ventures; Biomedical Research; Patrice Milos; Genomics; Genomic Testing; Life Technologies; Health Care and Treatment; Information Technology; Information Management; Genetics; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Boston; Massachusetts; United States
        Citation
        Educators
        Purchase
        Related
        Higgins, Robert F., and Matthew Preble. "Claritas Genomics." Harvard Business School Case 814-032, September 2013. (Revised August 2014.)
        • May 2006 (Revised June 2006)
        • Case

        Codon Devices

        By: Joseph B. Lassiter III and David Kiron
        In December 2005, 40-year-old John Danner was about to make his first presentation to the board of directors of Codon Devices, a one-year-old biotechnology start-up based in Cambridge, Massachusetts. After a month as the company's CEO, Danner was prepared to lay out... View Details
        Keywords: Strategic Planning; Venture Capital; Intellectual Property; Governing and Advisory Boards; Genetics; Competitive Advantage; Science-Based Business; Business Startups; Growth and Development Strategy; Biotechnology Industry; Cambridge
        Citation
        Find at Harvard
        Related
        Lassiter, Joseph B., III, and David Kiron. "Codon Devices." Harvard Business School Case 806-198, May 2006. (Revised June 2006.)
        • March 1996
        • Case

        Erox Corporation: Leverage Marketing

        Erox Corp. is a biotechnology start-up that creates products containing synthetic human pheromones. It was founded in 1989, went public in 1993, and brought in a turnaround team in 1994. Sales ramped from $110,000 in 1993 to over $1 million in 1994, with prospects for... View Details
        Keywords: Marketing Communications; Entrepreneurship; Biotechnology Industry
        Citation
        Educators
        Purchase
        Related
        Kosnik, Thomas J. "Erox Corporation: Leverage Marketing." Harvard Business School Case 596-046, March 1996.
        • 14 Jul 2023
        • Blog Post

        Harvard Business School Announces Its 2023-2024 Blavatnik Fellows

        offers HBS alumni and Harvard-affiliated postdocs the opportunity to work closely with leading biotech industry and biomedical authorities, receive mentorship, and join a community of entrepreneurs shaping the future of science. To date,... View Details
        • ←
        • 7
        • 8
        • …
        • 24
        • 25
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.